Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-21

Clinical Trial Update: Combined Replacement Therapy With Levothyroxine and Liothyronine in Thyroidectomized Patients [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating combined levothyroxine and liothyronine therapy in hypothyroid patients after thyroidectomy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levothyroxine (levothyroxine)
  • Liothyronine (liothyronine)

Snippet

Sponsor: Azienda USL Modena | Conditions: Hypothyroidism | Phase 2, Phase 3 | Status: COMPLETED